• No results found

Long-term outcome research on PDR brachytherapy with focus on breast, base of tongue and lip cancer

N/A
N/A
Protected

Academic year: 2021

Share "Long-term outcome research on PDR brachytherapy with focus on breast, base of tongue and lip cancer"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

2010

issn 1652-4063 isbn 978-91-7668-723-9

Bengt Johansson was born 1958 in Örebro, Sweden.

After an exam in electronic engineering 1978 he started the Medical studies at the University of Umeå and had his Medical Degree in 1984. Has been trained and working at Örebro University Hospital since 1984. He has now a position as Senior Consultant in Surgical Oncology and Radiotherapy at the Department of Oncology at Örebro University Hospital. He has been focused on clinical development and research on all kind of Brachytherapy since the early 1990’s and is now a well-known, national and international expert in this area. The Oncology Department at Örebro University Hospital was one of the pio-neers in the world in clinical use of Pulsed Dose Rate (PDR) Brachytherapy. A lot of experience has been collected during the years. Few long-term data on the effectiveness of PDR fractionation have been published. This thesis gives a comprehensive overview of the theoretical background, radiobiology experiments, early clinical results and clinical aspects of the PDR technology. Obtained long-term clinical results are presented for three different treat-ment situations and strongly support that PDR treattreat-ment results are similar to the classical continuous Low Dose Rate (LDR) brachytherapy. Thus, PDR is the ultimate, modern substitute for LDR brachytherapy and opens up for new future treatment areas of certain cancer diseases.

Örebro Studies in Medicine 42 örebro 2010

Doctoral Dissertation

Long-term outcome research on PDR brachytherapy

with focus on breast, base of tongue and lip cancer

Bengt Johansson Medicine

B

en

g

t J

o

h

a

n

ss

o

n

L on g-te rm o ut co m e r es ea rc h o n P D R b ra ch yt he ra py w ith f oc us o n b re as t, b as e o f t on gu e a nd l ip c an ce r

B

en

g

t

Jo

h

a

n

ss

o

n

Long-term outcome research on PDR brachytherapy

References

Related documents

Figure B.3: Inputs Process Data 2: (a) Frother to Rougher (b) Collector to Rougher (c) Air flow to Rougher (d) Froth thickness in Rougher (e) Frother to Scavenger (f) Collector

Paper III: 36 patients with pouch failure were compared to 72, age and gender matched patients with functioning pouches, regarding sexual function, body image

causes in lithium users), and to evaluate the role of lithium in the pathogenesis of ESRD; to test the hypothesis that modern lithium treatment routines have eliminated the risk

users), and to evaluate the role of lithium in the pathogenesis of ESRD; to test the hypothesis that modern lithium treatment routines have eliminated the risk of Li-ESRD

 A lower incidence of CMV infection/disease and acute cellular rejection was observed with valganciclovir prophylaxis when compared with oral ganciclovir,

series, to determine the 10 year survival rate and clinical outcome in younger patients, to assess the outcome in patients with spontaneous osteonecrosis of the knee, to report the

[r]

To compare the occurrence of symptoms (late side-effects) 10 to 17 years after breast irradiation we used a cohort of women who were randomised to receive tangential